Plant biotechnology's rush to market

Monsanto's shareholders have seen the value of their shares increase four-fold since 1994. Still, even faithful investors may have paused for thought as they read the explanation offered in the group's latest annual report for a 15% dividend cut.

Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120

The ENDS Report - subscribe today